Science News : ESC 2013 : Thrombosis

Updated:Sep 11,2013
 ESC 13 Header Banner 620 

Thrombosis Science
Elliot Antman, MD

Hot Line I: Late Breaking Trials on Thrombosis
ESC 13 Hokusai stillHokusai VTE
Edoxaban for the Long-term Treatment of Venous Thromboembolism

Related Science:

Related Statistics

Heart Disease and Stroke Statistics: 2013 Update
Circulation. 2013;127:21-23, published online before print December 13 2012, doi:10.1161/CIRCULATIONAHA.112.155911
  • Modeling suggests that >900 000 incident or recurrent VTE events occur annually in the United States, of which approximately one third are fatal.  VTE incidence has not changed significantly over the past 25 years.
  • PAD affects ≈8.5 million Americans aged ≥40 years and is associated with significant morbidity and mortality.42 PAD prevalence is higher in older individuals and appears to disproportionately affect African Americans.
  • In the general population, only ≈10% of people with PAD have the classic symptom of intermittent claudication.

Go to Hot Line II: Late Breaking Trials on Intervention and Devices >>

Go to ESC Congress 13 Science News Home Page

Scientific Sessions 2013 Banner 728x90 with dates

Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Professional Online Network

Connect with over 30,000 heart and stroke professionals.